These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 5090059

  • 1. Effect of lipids on growth hormone secretion in humans.
    Blackard WG, Hull EW, Lopez A.
    J Clin Invest; 1971 Jul; 50(7):1439-43. PubMed ID: 5090059
    [Abstract] [Full Text] [Related]

  • 2. The influence of plasma triglycerides on human growth hormone response to arginine and insulin: a study in hyperlipemics and normal subjects.
    Muggeo M, Tiengo A, Fedele D, Crepaldi G.
    Horm Metab Res; 1975 Sep; 7(5):367-74. PubMed ID: 1183914
    [Abstract] [Full Text] [Related]

  • 3. Free fatty acid inhibition of exercise-induced growth hormone secretion.
    Casanueva F, Villanueva L, Penalva A, Vila T, Cabezas-Cerrato J.
    Horm Metab Res; 1981 Jun; 13(6):348-50. PubMed ID: 7262838
    [Abstract] [Full Text] [Related]

  • 4. Effect of lipids on glucagon secretion in man.
    Andrews SS, Lopez-S A, Blackard WG.
    Metabolism; 1975 Jan; 24(1):35-44. PubMed ID: 1110625
    [Abstract] [Full Text] [Related]

  • 5. Hormonal and metabolic changes induced by elevated plasma free fatty acids in term pregnancy. I. Effect on maternal blood glucose, insulin and human placental lactogen circulating levels.
    Gaspard UJ, Sandront HM, Luyckx AS, Lefebvre PJ.
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1066-72. PubMed ID: 1133156
    [Abstract] [Full Text] [Related]

  • 6. Studies on the relationship between plasma free fatty acids and growth hormone secretion in man.
    Quabbe HJ, Bratzke HJ, Siegers U, Elban K.
    J Clin Invest; 1972 Sep; 51(9):2388-98. PubMed ID: 4639023
    [Abstract] [Full Text] [Related]

  • 7. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D, Luyckx AS, Lefebvre PJ.
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [Abstract] [Full Text] [Related]

  • 8. [Effects of heparin on HGH secretion after intravenous administration of tolbutamide in normal subjects].
    Ragonese F, Melluso R, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1975-9. PubMed ID: 1231882
    [No Abstract] [Full Text] [Related]

  • 9. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.
    Gerich JE, Langlois M, Schneider V, Karam JH, Noacco C.
    J Clin Invest; 1974 May 30; 53(5):1284-9. PubMed ID: 4825225
    [Abstract] [Full Text] [Related]

  • 10. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M.
    J Clin Invest; 1971 May 30; 50(5):1069-79. PubMed ID: 4928263
    [Abstract] [Full Text] [Related]

  • 11. Glucagon-initiated human growth hormone release: a comparative study.
    Cain JP, Williams GH, Dluhy RG.
    Can Med Assoc J; 1972 Oct 07; 107(7):617-22. PubMed ID: 4665093
    [Abstract] [Full Text] [Related]

  • 12. Hormonal and metabolic effects of somatostatin in diabetic patients submitted to an i.v. arginine infusion.
    Assan R, Heuclin C, Girard JR, Basdevant A, Predine J, Husson JM.
    Diabete Metab; 1977 Mar 07; 3(1):11-7. PubMed ID: 870353
    [Abstract] [Full Text] [Related]

  • 13. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U.
    Exp Clin Endocrinol Diabetes; 2003 Aug 07; 111(5):246-50. PubMed ID: 12951628
    [Abstract] [Full Text] [Related]

  • 14. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May 07; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 15. Chronobiological pattern of growth hormone secretion in normal subjects and in retinopathic diabetics. Lack of suppression by a plurichronocorticoid drug.
    Muggeo M, Molinari M, Baiocchi A, Tiengo A, Fedele D, Crepaldi G.
    Chronobiologia; 1976 May 07; 3(4):323-34. PubMed ID: 1030662
    [Abstract] [Full Text] [Related]

  • 16. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC, Frisch F, Cyr D, Généreux P, Patterson BW, Giguère R, Baillargeon JP.
    Am J Physiol Endocrinol Metab; 2005 Nov 07; 289(5):E849-56. PubMed ID: 15972273
    [Abstract] [Full Text] [Related]

  • 17. Alcohol hypoglycemia: hormonal changes.
    Andreani D, Tamburrano G, Javicoli M.
    Horm Metab Res; 1976 Nov 07; Suppl 6():99-105. PubMed ID: 1278844
    [Abstract] [Full Text] [Related]

  • 18. [The effect of an infusion of glucose-insulin-potassium and of heparin on the plasma free fatty acid levels and on blood glucose].
    Haslauer F, Krempler F, Bolzano K, Sandhofer F.
    Wien Klin Wochenschr; 1983 Sep 16; 95(17):618-21. PubMed ID: 6359725
    [Abstract] [Full Text] [Related]

  • 19. [Somatotropin secretion stimulation test for diencephalic and pituitary diseases, with special reference to the tests using arginine and insulin].
    Nakagawa K, Okamoto M, Horiuchi Y, Mashimo K.
    Saishin Igaku; 1969 Nov 16; 24(11):2333-9. PubMed ID: 5359819
    [No Abstract] [Full Text] [Related]

  • 20. The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man.
    Abrams RL, Grumbach MM, Kaplan SL.
    J Clin Invest; 1971 Apr 16; 50(4):940-50. PubMed ID: 4926262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.